ADVERTISEMENT
An illustration of a small number of virus particles on a blurred background.
A New Piece in the HIV Replication Puzzle
A host lipid-modifying enzyme plays a key role in HIV envelope formation, viral maturation, and infectivity. 
A New Piece in the HIV Replication Puzzle
A New Piece in the HIV Replication Puzzle

A host lipid-modifying enzyme plays a key role in HIV envelope formation, viral maturation, and infectivity. 

A host lipid-modifying enzyme plays a key role in HIV envelope formation, viral maturation, and infectivity. 

HIV

Accessible Lateral Flow Assays: Test to Treat, Test to Protect
Deanna MacNeil, PhD | Oct 18, 2023 | 3 min read
From development to implementation, Rosanna Peeling discusses the importance of rapid tests for public health.
Blood vessel with flowing red blood cells and white immune cells.
New CRISPR Treatment Could Prevent HIV Reinfection after Viral DNA Excision
Jennifer Zieba, PhD | Aug 21, 2023 | 3 min read
Researchers design dual CRISPR treatments to remove HIV DNA and prevent reinfection in vitro.
Molecular Farming: The Future of Pharmaceuticals
The Scientist Speaks - Molecular Farming: The Future of Pharmaceuticals
Niki Spahich, PhD | 1 min read
Julian Ma discusses past, present, and future uses of plant biotechnology for disease treatments.
Fluorescence image in purple and green of lymph node
Targeting Antigen “Sanctuary” in Lymph Nodes Could Make Vaccines Better
Natalia Mesa, PhD | Feb 10, 2023 | 3 min read
Researchers find that small sacks inside lymph nodes contain low proteolytic activity and act as safe havens for antigens.
Illustration of HIV virus
Viral Protein Behind Chronic Inflammation in People with HIV: Study
Natalia Mesa, PhD | Dec 12, 2022 | 3 min read
The HIV protein Nef can cause long-term genetic changes that lead to hyperreactive immune cells, according to research in human cells and mice. 
Discover new treatments for pandemic diseases
Treatments for Disease Pandemics
The Scientist | 1 min read
Researchers develop new vaccines and therapeutics to combat the spread of infectious diseases.
A germinal center inside a lymph node
Slow Vaccine Delivery May Maximize Immune Response
Alejandra Manjarrez, PhD | Sep 23, 2022 | 5 min read
A vaccine strategy involving formulation changes, an initial escalating dose, and a longer wait for booster immunization results in more-effective antibody production against HIV in rhesus monkeys, a study finds.
3D virus cells attacking a DNA strand
HIV DNA Circularizes to Bypass CRISPR-Based Treatments
Nele Haelterman, PhD | Mar 7, 2022 | 3 min read
CRISPR-mediated removal of HIV can create small, infectious DNA molecules.
Scientific Breakthroughs with Cryogenic Electron Microscopy
The Scientist and Thermo Fisher Scientific | 1 min read
Structures made via cryo-EM give researchers insights into SARS-CoV-2, HIV, neurological disorders, cancer, and more.
Blue T cell with other blurred T cells in the background
Woman Seemingly Cured of HIV After Umbilical Cord Transplant
Natalia Mesa, PhD | Feb 16, 2022 | 3 min read
Umbilical cord blood may be a good alternative to bone marrow transplants for treating HIV in patients with HIV and cancer.
Photo of carved bust in front of building labeled "Institut Pasteur"
Luc Montagnier, Virologist who Codiscovered HIV, Dies at Age 89
Natalia Mesa, PhD | Feb 11, 2022 | 3 min read
The Nobel laureate had courted controversy in recent years on vaccines and other matters.
Transforming Virology Research with Cryo-EM
The Scientist and Thermo Fisher Scientific | 1 min read
Explore what researchers can do with Cryo-EM
sign reading "bio-security precautions, no unauthorized personnel"
Opinion: Coronavirus and Regulating Access to High-Risk Pathogens
Michael Parker, Shreya Kalra, and Bryce Kassalow | Feb 10, 2022 | 10+ min read
Overbearing restrictions on research into toxins and pathogens such as SARS-CoV-2 could undermine public health and security in the long run.
Collage of those featured in the article
Remembering Those We Lost in 2021
Lisa Winter | Dec 23, 2021 | 5 min read
As the year draws to a close, we look back on researchers we bid farewell to, and the contributions they made to their respective fields.
How Infectious Diseases Affect the Brain
The Scientist | 1 min read
From a loss of taste to dementia, infectious agents cause an array of neurological symptoms.
orange and blue cell image
Woman’s Body Appears to Rid Itself of HIV
Chloe Tenn | Nov 18, 2021 | 3 min read
Researchers report what appears to be the second case of a person’s immune system clearing the virus on its own.
CAR T Cells Derived from Stem Cells Target HIV Tissue Reservoirs in Monkeys
Berly McCoy, PhD | May 25, 2021 | 3 min read
Transplanted CAR stem cells persisted long term and showed multilineage engraftment in tissues that harbor HIV.
COVID-19, SARS-CoV-2, coronavirus, pandemic, pseudovirus, chimeric virus, disease & medicine, techniques, HIV, VSV, vaccine, variants, mutations
What Pseudoviruses Bring to the Study of SARS-CoV-2
Amanda Heidt | Feb 16, 2021 | 7 min read
Engineered viruses that don’t replicate provide a tractable model for scientists to safely study SARS-CoV-2, including research into vaccine efficacy and emerging variants.
obituary, obituaries, roundup, end of the year, COVID-19, SARS-CoV-2, pandemic, coronavirus, immunology, genetics & genomics, cell & molecular biology, HIV
Those We Lost in 2020
Amanda Heidt | Dec 18, 2020 | 7 min read
The scientific community bid farewell to researchers who furthered the fields of molecular biology, virology, sleep science, and immunology, among others.
ADVERTISEMENT